ZUDDAS, ALESSANDRO
ZUDDAS, ALESSANDRO
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl pyridinium uptake in dissociated cell cultures from embryonic mesencephalon
1988-01-01 Schinelli, S; Zuddas, Alessandro; Kopin, Ij; Barker, Jl; DI PORZIO, U.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyrydyne (MPTP) neurotoxicity in mice is enhanced by ethanol or acethaldehyde
1987-01-01 Corsini, Gu; Zuddas, Alessandro; Bonucceli, B; Schinelli, S; Kopinij,
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome
2022-01-01 Gagliano, Antonella; Murgia, Federica; Capodiferro, Agata Maria; Tanca, Marcello Giuseppe; Hendren, Aran; Falqui, Stella Giulia; Aresti, Michela; Comini, Martina; Carucci, Sara; Cocco, Eleonora; Lorefice, Lorena; Roccella, Michele; Vetri, Luigi; Sotgiu, Stefano; Zuddas, Alessandro; Atzori, Luigi
6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1: a cellular model of Dopa-responsive dystonia
2002-01-01 Zuddas, Alessandro; C., Mancosu; V., Lilliu; Sorrentino, G; DI PORZIO, U; C., Cianchetti
[Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions] (German).
2008-01-01 Banaschewski, T; EUNETHYDIS Guidelines, Group; Incl, ; Zuddas, Alessandro
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations]. (German)
2008-01-01 Banaschewski, T; Coghill, D; Santosh, P; Zuddas, Alessandro; Asherson, P; Buitelaar, J; Danckaerts, M; Döpfner, M; Faraone, Sv; Rothenberger, A; Sergeant, J; Steinhausen, Hc; SONUGA BARKE, Ej; Taylor, E.
[Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]. ( German)
2008-01-01 Banaschewski, T; Coghill, D; Santosh, P; Zuddas, Alessandro; Asherson, P; Buitelaar, J; Danckaerts, M; Döpfner, M; Faraone, Sv; Rothenberger, A; Sergeant, J; Steinhausen, Hc; SONUGA BARKE, Ej; Taylor, E.
A comparison of North American versus non-North American ADHD study populations
2006-01-01 Jk, Buitelaar; J., Barton; M., Danckaerts; E., Friedrichs; Gillberg, C; Hazell, Pl; Hellemans, H; Johnson, M; Kalverdijk, Lj; Masi, G; Michelson, D; Revol, O; Sebastian, Js; Zhang, S; Zuddas, Alessandro
A crucial role for basic emotion awareness in the development of emotion regulation?
2012-01-01 Zuddas, Alessandro
A neurodevelopment approach for a transitional model of early onset schizophrenia
2021-01-01 De Berardis, D.; De Filippis, S.; Masi, G.; Vicari, S.; Zuddas, A.
A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents
2013-01-01 Soutullo, C; Banaschewski, T; Lecendreux, M; Johnson, M; Zuddas, Alessandro; Anderson, C; Civil, R; Higgins, N; Bloomfield, R; Squires, La; Coghill, D. R.
A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD
2004-01-01 Buitelaar, J. K.; J., Gadoros; V., Harpin; P., Hazell; M., Johnson; T., LERMAN SAGIE; Soutullo, C. A.; T., Wolanczyk; P., Zeiner; Zuddas, Alessandro; Fouche, D. S.; J., KRIKKE WORKEL; S., Zhang; D., Michelson
A randomized, double-blind study of continuation treatment for ADHD after one year
2007-01-01 Buitelaar, J. K.; D., Michelson; M., Danckaerts; C., Gillberg; Spencer, T. J.; Zuddas, Alessandro; Faries, D. E.; S., Zhang; J., Biederman
Acetaldehyde directly enhances MPP+ toxicity and delays its elimination from the striatum
1989-01-01 Zuddas, Alessandro; Corsini, Gu; Schinelli, S; Barker, Jl; Kopin, Ij; DI PORZIO, U.
ADHD and hyperkinetic disorder
2015-01-01 Tobias, Banaschewski; Zuddas, Alessandro; Philip, Asherson; Jan, Buitelaar; David, Coghill; Marina, Danckaerts; Manfred, Döpfner; Luis Augusto, Rohde; Edmund Sonuga, Barke; Eric, Taylor
ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group
2020-01-01 Cortese, S.; Asherson, P.; Sonuga-Barke, E.; Banaschewski, T.; Brandeis, D.; Buitelaar, J.; Coghill, D.; Daley, D.; Danckaerts, M.; Dittmann, R. W.; Doepfner, M.; Ferrin, M.; Hollis, C.; Holtmann, M.; Konofal, E.; Lecendreux, M.; Santosh, P.; Rothenberger, A.; Soutullo, C.; Steinhausen, H. -C.; Taylor, E.; Van der Oord, S.; Wong, I.; Zuddas, A.; Simonoff, E.
Antipsychotics for non-psychotic disorders
2009-01-01 Zuddas, Alessandro; Paba, S; Usala, T.
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
2009-01-01 Vitiello, B; Correll, C; VAN ZWIETEN BOOT, B; Zuddas, Alessandro; Parellada, M; Arango, C.
Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion
1991-01-01 Bankiewicz, Ks; Oldfield, Eh; Plunkett, Rj; Schuette, Wh; Cogank, Dg; Hogan, N; Zuddas, Alessandro; Kopin, Ij
Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart review
2009-01-01 Paba, Silvia; Lecca, L; Testa, M; Atzori, P; Zuddas, Alessandro
| Titolo | Data di pubblicazione | Autore(i) | Rivista | Editore |
|---|---|---|---|---|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl pyridinium uptake in dissociated cell cultures from embryonic mesencephalon | 1-gen-1988 | Schinelli, S; Zuddas, Alessandro; Kopin, Ij; Barker, Jl; DI PORZIO, U. | JOURNAL OF NEUROCHEMISTRY | - |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrydyne (MPTP) neurotoxicity in mice is enhanced by ethanol or acethaldehyde | 1-gen-1987 | Corsini, Gu; Zuddas, Alessandro; Bonucceli, B; Schinelli, S; Kopinij, | LIFE SCIENCES | - |
| 1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome | 1-gen-2022 | Gagliano, Antonella; Murgia, Federica; Capodiferro, Agata Maria; Tanca, Marcello Giuseppe; Hendren, Aran; Falqui, Stella Giulia; Aresti, Michela; Comini, Martina; Carucci, Sara; Cocco, Eleonora; Lorefice, Lorena; Roccella, Michele; Vetri, Luigi; Sotgiu, Stefano; Zuddas, Alessandro; Atzori, Luigi | JOURNAL OF CLINICAL MEDICINE | - |
| 6R-Tetrahydrobiopterin induces dopamine synthesis in a human neuroblastoma cell line, LA-N-1: a cellular model of Dopa-responsive dystonia | 1-gen-2002 | Zuddas, Alessandro; C., Mancosu; V., Lilliu; Sorrentino, G; DI PORZIO, U; C., Cianchetti | BRAIN RESEARCH | - |
| [Joint position of the Guideline Group of the European Network for Hyperkintetic Disorders (EUNETHYDIS) and the German Central ADHD Network for ECG Recording on methylphenidate prescriptions] (German). | 1-gen-2008 | Banaschewski, T; EUNETHYDIS Guidelines, Group; Incl, ; Zuddas, Alessandro | ZEITSCHRIFT FUR KINDER- UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE | - |
| [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guideline. Part 1: overview and recommendations]. (German) | 1-gen-2008 | Banaschewski, T; Coghill, D; Santosh, P; Zuddas, Alessandro; Asherson, P; Buitelaar, J; Danckaerts, M; Döpfner, M; Faraone, Sv; Rothenberger, A; Sergeant, J; Steinhausen, Hc; SONUGA BARKE, Ej; Taylor, E. | ZEITSCHRIFT FUR KINDER- UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE | - |
| [Long-acting medications for the treatment of hyperkinetic disorders - a systematic review and European treatment guidelines. Part 2: a quantitative evaluation of long-acting medications]. ( German) | 1-gen-2008 | Banaschewski, T; Coghill, D; Santosh, P; Zuddas, Alessandro; Asherson, P; Buitelaar, J; Danckaerts, M; Döpfner, M; Faraone, Sv; Rothenberger, A; Sergeant, J; Steinhausen, Hc; SONUGA BARKE, Ej; Taylor, E. | ZEITSCHRIFT FUR KINDER- UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE | - |
| A comparison of North American versus non-North American ADHD study populations | 1-gen-2006 | Jk, Buitelaar; J., Barton; M., Danckaerts; E., Friedrichs; Gillberg, C; Hazell, Pl; Hellemans, H; Johnson, M; Kalverdijk, Lj; Masi, G; Michelson, D; Revol, O; Sebastian, Js; Zhang, S; Zuddas, Alessandro | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | - |
| A crucial role for basic emotion awareness in the development of emotion regulation? | 1-gen-2012 | Zuddas, Alessandro | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | - |
| A neurodevelopment approach for a transitional model of early onset schizophrenia | 1-gen-2021 | De Berardis, D.; De Filippis, S.; Masi, G.; Vicari, S.; Zuddas, A. | BRAIN SCIENCES | - |
| A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents | 1-gen-2013 | Soutullo, C; Banaschewski, T; Lecendreux, M; Johnson, M; Zuddas, Alessandro; Anderson, C; Civil, R; Higgins, N; Bloomfield, R; Squires, La; Coghill, D. R. | CNS DRUGS | - |
| A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD | 1-gen-2004 | Buitelaar, J. K.; J., Gadoros; V., Harpin; P., Hazell; M., Johnson; T., LERMAN SAGIE; Soutullo, C. A.; T., Wolanczyk; P., Zeiner; Zuddas, Alessandro; Fouche, D. S.; J., KRIKKE WORKEL; S., Zhang; D., Michelson | EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | - |
| A randomized, double-blind study of continuation treatment for ADHD after one year | 1-gen-2007 | Buitelaar, J. K.; D., Michelson; M., Danckaerts; C., Gillberg; Spencer, T. J.; Zuddas, Alessandro; Faries, D. E.; S., Zhang; J., Biederman | BIOLOGICAL PSYCHIATRY | - |
| Acetaldehyde directly enhances MPP+ toxicity and delays its elimination from the striatum | 1-gen-1989 | Zuddas, Alessandro; Corsini, Gu; Schinelli, S; Barker, Jl; Kopin, Ij; DI PORZIO, U. | BRAIN RESEARCH | - |
| ADHD and hyperkinetic disorder | 1-gen-2015 | Tobias, Banaschewski; Zuddas, Alessandro; Philip, Asherson; Jan, Buitelaar; David, Coghill; Marina, Danckaerts; Manfred, Döpfner; Luis Augusto, Rohde; Edmund Sonuga, Barke; Eric, Taylor | - | Oxford University Press |
| ADHD management during the COVID-19 pandemic: guidance from the European ADHD Guidelines Group | 1-gen-2020 | Cortese, S.; Asherson, P.; Sonuga-Barke, E.; Banaschewski, T.; Brandeis, D.; Buitelaar, J.; Coghill, D.; Daley, D.; Danckaerts, M.; Dittmann, R. W.; Doepfner, M.; Ferrin, M.; Hollis, C.; Holtmann, M.; Konofal, E.; Lecendreux, M.; Santosh, P.; Rothenberger, A.; Soutullo, C.; Steinhausen, H. -C.; Taylor, E.; Van der Oord, S.; Wong, I.; Zuddas, A.; Simonoff, E. | THE LANCET CHILD & ADOLESCENT HEALTH | - |
| Antipsychotics for non-psychotic disorders | 1-gen-2009 | Zuddas, Alessandro; Paba, S; Usala, T. | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns | 1-gen-2009 | Vitiello, B; Correll, C; VAN ZWIETEN BOOT, B; Zuddas, Alessandro; Parellada, M; Arango, C. | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |
| Apparent unilateral visual neglect in MPTP-hemiparkinsonian monkeys is due to delayed initiation of motion | 1-gen-1991 | Bankiewicz, Ks; Oldfield, Eh; Plunkett, Rj; Schuette, Wh; Cogank, Dg; Hogan, N; Zuddas, Alessandro; Kopin, Ij | BRAIN RESEARCH | - |
| Are risperidone safety and tolerability in children and adolescents modulated by diagnosis? A retrospective chart review | 1-gen-2009 | Paba, Silvia; Lecca, L; Testa, M; Atzori, P; Zuddas, Alessandro | EUROPEAN NEUROPSYCHOPHARMACOLOGY | - |